You are here

COVID-19

CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis

CRISPR Therapeutics braces for 'severe impact' from COVID-19 crisis

Fierce Biotech

CRISPR Therapeutics

clinical trials

Flag link:

The scramble to reinvent the ventilator

The scramble to reinvent the ventilator

EP Vantage

Flag link:

VBI Vaccines collaborates with the National Research Council of Canada to develop pan-coronavirus vaccine candidate

VBI Vaccines collaborates with the National Research Council of Canada to develop pan-coronavirus vaccine candidate

Pharmaceutical Business Review

Flag link:

Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead

Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead

Fierce Pharma

Moderna Therapeutics

Flag link:

A Vaccine From The 1920s Is Now Being Tested For Use Against The Coronavirus Pandemic

A Vaccine From The 1920s Is Now Being Tested For Use Against The Coronavirus Pandemic

Forbes

Flag link:

Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns

Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns

Fierce Pharma

Flag link:

New FDA Program to Accelerate Coronavirus Treatments

New FDA Program to Accelerate Coronavirus Treatments

RAPS.org

Flag link:

Abbott Brings Rapid Testing to the Front Lines

Abbott Brings Rapid Testing to the Front Lines

Medical Devices and Diagnostics Industry

Flag link:

Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling

Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling

STAT

Flag link:

Noveome to assess ST266 to treat severe inflammatory response linked with COVID-19

Noveome to assess ST266 to treat severe inflammatory response linked with COVID-19

Pharmaceutical Business Review

Noveome Biotherapeutics

Flag link:

COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout

COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout

Fierce Biotech

clinical trials

Flag link:

Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug

Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug

Fierce Biotech

clinical trials

Flag link:

COVID-19 could cause ‘digital reset’ for pharma

COVID-19 could cause ‘digital reset’ for pharma

Pharmaforum

pharma marketing

Flag link:

Medtronic Makes Plans for a Ventilator Open-Source

Medtronic Makes Plans for a Ventilator Open-Source

Motley Fool

Flag link:

Amid Concerns of Shortage, FDA Issues Emergency Use Authorization for Ventilators, Accessories and Other Respiratory Devices

Amid Concerns of Shortage, FDA Issues Emergency Use Authorization for Ventilators, Accessories and Other Respiratory Devices

FDA Law Blog

medical supplies

Flag link:

Reata Pharmaceuticals Says Ongoing Trials In Patients With Pulmonary Arterial Hypertension Stopped Due To High Risk Of COVID-19 To These Patients

Reata Pharmaceuticals Says Ongoing Trials In Patients With Pulmonary Arterial Hypertension Stopped Due To High Risk Of COVID-19 To These Patients

Reuters

Reata Pharmaceuticals

clinical trials

Flag link:

Equal coronavirus vaccine access a “real issue”

Equal coronavirus vaccine access a “real issue”

Pharmaforum

Flag link:

COVID-19 causes Moderna to pause a clutch of clinical trials

COVID-19 causes Moderna to pause a clutch of clinical trials

Fierce Biotech

Moderna Therapeutics

clinical trials

Flag link:

CRISPR pioneer Doudna opens lab to run Covid-19 tests

CRISPR pioneer Doudna opens lab to run Covid-19 tests

Stat

Jennifer Doudna

Flag link:

Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19

Aveo gives up on ficlatuzumab in acute myeloid leukemia, citing COVID-19

Fierce Biotech

clinical trials

Flag link:

Pages